KOD
Price
$3.53
Change
-$0.53 (-13.05%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
186.52M
89 days until earnings call
RCKT
Price
$6.60
Change
-$0.25 (-3.65%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
709.99M
82 days until earnings call
Interact to see
Advertisement

KOD vs RCKT

Header iconKOD vs RCKT Comparison
Open Charts KOD vs RCKTBanner chart's image
Kodiak Sciences
Price$3.53
Change-$0.53 (-13.05%)
Volume$4.45K
Capitalization186.52M
Rocket Pharmaceuticals
Price$6.60
Change-$0.25 (-3.65%)
Volume$60.24K
Capitalization709.99M
KOD vs RCKT Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. RCKT commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Buy and RCKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (KOD: $3.54 vs. RCKT: $6.59)
Brand notoriety: KOD and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 126% vs. RCKT: 78%
Market capitalization -- KOD: $186.52M vs. RCKT: $709.99M
KOD [@Biotechnology] is valued at $186.52M. RCKT’s [@Biotechnology] market capitalization is $709.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both KOD and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 6 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • KOD’s TA Score: 6 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KOD is a better buy in the short-term than RCKT.

Price Growth

KOD (@Biotechnology) experienced а -10.28% price change this week, while RCKT (@Biotechnology) price change was +8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

KOD is expected to report earnings on Aug 18, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($710M) has a higher market cap than KOD($187M). RCKT YTD gains are higher at: -47.574 vs. KOD (-64.472). KOD has higher annual earnings (EBITDA): -164.93M vs. RCKT (-246.03M). RCKT has more cash in the bank: 318M vs. KOD (198M). RCKT has less debt than KOD: RCKT (25.4M) vs KOD (73.4M). KOD (0) and RCKT (0) have equivalent revenues.
KODRCKTKOD / RCKT
Capitalization187M710M26%
EBITDA-164.93M-246.03M67%
Gain YTD-64.472-47.574136%
P/E RatioN/AN/A-
Revenue00-
Total Cash198M318M62%
Total Debt73.4M25.4M289%
FUNDAMENTALS RATINGS
KOD vs RCKT: Fundamental Ratings
KOD
RCKT
OUTLOOK RATING
1..100
2666
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
5465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (28) in the Biotechnology industry is in the same range as RCKT (28). This means that KOD’s stock grew similarly to RCKT’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that KOD’s stock grew similarly to RCKT’s over the last 12 months.

RCKT's SMR Rating (94) in the Biotechnology industry is in the same range as KOD (95). This means that RCKT’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (54) in the Biotechnology industry is in the same range as RCKT (65). This means that KOD’s stock grew similarly to RCKT’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that KOD’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODRCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIRX53.92N/A
N/A
Hartford Core Equity R3
BTMFX24.72N/A
N/A
Boston Trust Midcap
SISEX26.42N/A
N/A
Shelton International Select Eq Inst
CGEZX20.33N/A
N/A
Columbia Select Global Equity Inst
MNDBX14.43-0.42
-2.83%
MFS New Discovery B

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-12.93%
XNCR - KOD
50%
Loosely correlated
-7.62%
RCKT - KOD
49%
Loosely correlated
-3.80%
RGNX - KOD
48%
Loosely correlated
-3.60%
KYMR - KOD
47%
Loosely correlated
-4.17%
IMNM - KOD
47%
Loosely correlated
-7.48%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-3.80%
NTLA - RCKT
61%
Loosely correlated
-4.86%
XNCR - RCKT
60%
Loosely correlated
-7.62%
ACLX - RCKT
59%
Loosely correlated
+8.26%
RGNX - RCKT
58%
Loosely correlated
-3.60%
KYMR - RCKT
58%
Loosely correlated
-4.17%
More